Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data
Bio Expo
Champignondagen
  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • NewsBusiness

IntegriChain Strengthens Leadership to Accelerate Innovation and Customer-Centric Growth

  • The Pharma Data
  • August 19, 2025

IntegriChain Appoints New Chief AI and Technology Officer to Lead Next Era of Innovation, Automation, and Customer Experience in Life Sciences IntegriChain, a recognized market leader in net revenue optimization…

Read MoreIntegriChain Strengthens Leadership to Accelerate Innovation and Customer-Centric Growth
  • Research

jCyte Begins Patient Treatment in Phase JC02-88 Clinical Trial for Retinitis Pigmentosa

  • The Pharma Data
  • August 19, 2025

jCyte Marks Major Milestone with First Patients Treated in JC02-88 Clinical Trial Evaluating jCell for Retinitis Pigmentosa jCyte, Inc., a clinical-stage biotechnology company pioneering cell-based therapies for retinal diseases, announced…

Read MorejCyte Begins Patient Treatment in Phase JC02-88 Clinical Trial for Retinitis Pigmentosa
  • Press Releases

ConcertAI Names Michael Myshrall as New Chief Financial Officer

  • The Pharma Data
  • August 19, 2025

ConcertAI Appoints Michael Myshrall as Chief Financial Officer, Strengthening Financial Leadership to Drive Growth in AI-Powered Healthcare and Life Sciences ConcertAI, a global leader in oncology generative and agentic artificial…

Read MoreConcertAI Names Michael Myshrall as New Chief Financial Officer
Oncology
  • Regulatory

Ifinatamab Deruxtecan Receives FDA Breakthrough Therapy Designation in SCLC

  • The Pharma Data
  • August 19, 2025

Ifinatamab Deruxtecan Receives Breakthrough Therapy Designation from FDA for Pretreated Extensive-Stage Small Cell Lung Cancer The oncology research landscape took a significant step forward this week with the announcement that…

Read MoreIfinatamab Deruxtecan Receives FDA Breakthrough Therapy Designation in SCLC
  • RegulatoryNews

Grove Biopharma to Join ACS Fall 2025 Materials Biology Symposium

  • The Pharma Data
  • August 16, 2025

Grove Biopharma to Showcase Breakthrough Bionic Biologics™ at ACS Fall 2025 Symposium on Materials Biology Grove Biopharma, a private biotechnology company advancing an innovative therapeutic approach it calls Bionic Biologics™,…

Read MoreGrove Biopharma to Join ACS Fall 2025 Materials Biology Symposium
  • Regulatory

FluMist, the Only Nasal Spray Flu Vaccine in the U.S., Now Offered Through Home Delivery

  • The Pharma Data
  • August 16, 2025

AstraZeneca Launches FluMist Home: First Nationwide At-Home Delivery Service for Needle-Free Influenza Vaccination AstraZeneca has announced the launch of FluMist Home, a pioneering direct-to-consumer initiative that will allow individuals and…

Read MoreFluMist, the Only Nasal Spray Flu Vaccine in the U.S., Now Offered Through Home Delivery
  • Press ReleasesResearch

RenovoRx Posts Q2 2025 Growth, Phase III Trial Cleared to Continue

  • The Pharma Data
  • August 16, 2025

RenovoRx Reports Strong Q2 2025 Revenue Growth and Receives Positive Independent Committee Recommendation to Continue Phase III TIGeR-PaC Trial RenovoRx, Inc. (Nasdaq: RNXT), a clinical-stage life sciences company pioneering targeted…

Read MoreRenovoRx Posts Q2 2025 Growth, Phase III Trial Cleared to Continue
  • News

Omeros Corporation Announces Financial Results for Q2 2025

  • The Pharma Data
  • August 16, 2025

Omeros Corporation Reports Second Quarter 2025 Financial Results, Advances Narsoplimab Regulatory Reviews, and Strengthens Balance Sheet Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company dedicated to developing novel therapeutics for serious…

Read MoreOmeros Corporation Announces Financial Results for Q2 2025
  • Research

ScaleReady Awards G-Rex® Grant to Gates Institute’s Translational Sciences Laboratory

  • The Pharma Data
  • August 16, 2025

ScaleReady Awards $300,000 G-Rex® Grant to Gates Institute’s Translational Sciences Laboratory to Advance Modular CAR T-Cell Manufacturing ScaleReady, a joint venture formed by Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady,…

Read MoreScaleReady Awards G-Rex® Grant to Gates Institute’s Translational Sciences Laboratory
  • ResearchPress Releases

SAPPHIRE Trial: Apitegromab Boosts Motor Function in SMA, Published in The Lancet Neurology

  • The Pharma Data
  • August 15, 2025

Scholar Rock Announces Landmark Lancet Neurology Publication of Pivotal Phase 3 SAPPHIRE Trial Results for Apitegromab in Spinal Muscular Atrophy Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company dedicated to…

Read MoreSAPPHIRE Trial: Apitegromab Boosts Motor Function in SMA, Published in The Lancet Neurology
Nu-Tek BioSciences
  • Regulatory

Nu-Tek BioSciences Showcases Animal-Free Cell Culture at BPI East 2025

  • The Pharma Data
  • August 15, 2025

Nu-Tek BioSciences to Showcase 100% Animal-Free Peptones and Yeast Extracts at BPI East 2025, Driving the Future of Sustainable Cell Culture and Fermentation In an era where biopharmaceutical manufacturers are…

Read MoreNu-Tek BioSciences Showcases Animal-Free Cell Culture at BPI East 2025
  • News

Cybin Announces Key Milestone Achievements and First Quarter FY2026 Financial Update

  • The Pharma Data
  • August 15, 2025

Cybin Announces Major Clinical and Regulatory Milestones Alongside First Quarter Fiscal Year 2026 Financial Results Cybin Inc. (NYSE American: CYBN) (Cboe Canada: CYBN), a clinical-stage breakthrough neuropsychiatry company focused on…

Read MoreCybin Announces Key Milestone Achievements and First Quarter FY2026 Financial Update
PrevNext
UK Biotech Day
Global Clinical
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Element Science Recognized on Fast Company’s 2026 List of the World’s Most Innovative Companies
  • NBDF’s Pathway to Cures Backs LUNA Trial for Non-Drug Treatment of Heavy Menstrual Bleeding
  • Roseman University Unveils Roseman Bioventures, a 120,000-Square-Foot Life Sciences Incubator in Las Vegas
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.